Also, ECs treated with conditioned medium from cholangiocarcinoma cells containing a constitutively active YAP mutation (YAP S127A), showed increased tube formation capacity in vitro (102), suggesting enhanced endothelial activity. This evidence concerns the gene YAP1 and cholangiocarcinoma.